Camp4 Therapeutics Poration Stock Market Capitalization
| CAMP Stock | USD 1.65 0.02 1.23% |
CAMP4 THERAPEUTICS's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting CAMP4 Stock price.
| Last Reported | Projected for Next Year | ||
| Market Cap | 91.6 M | 131.7 M |
CAMP4 | Market Capitalization | Build AI portfolio with CAMP4 Stock |
CAMP4 THERAPEUTICS PORATION Company Market Capitalization Analysis
CAMP4 THERAPEUTICS's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current CAMP4 THERAPEUTICS Market Capitalization | 102.82 M |
Most of CAMP4 THERAPEUTICS's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CAMP4 THERAPEUTICS PORATION is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
CAMP4 Market Capitalization Driver Correlations
Understanding the fundamental principles of building solid financial models for CAMP4 THERAPEUTICS is extremely important. It helps to project a fair market value of CAMP4 Stock properly, considering its historical fundamentals such as Market Capitalization. Since CAMP4 THERAPEUTICS's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CAMP4 THERAPEUTICS's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CAMP4 THERAPEUTICS's interrelated accounts and indicators.
Click cells to compare fundamentals
CAMP4 Market Capitalization Historical Pattern
Today, most investors in CAMP4 THERAPEUTICS Stock are looking for potential investment opportunities by analyzing not only static indicators but also various CAMP4 THERAPEUTICS's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's market capitalization growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of CAMP4 THERAPEUTICS market capitalization as a starting point in their analysis.
CAMP4 THERAPEUTICS Market Capitalization |
| Timeline |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
CAMP4 Long Term Debt To Capitalization
Long Term Debt To Capitalization |
|
Based on the recorded statements, the market capitalization of CAMP4 THERAPEUTICS PORATION is about 102.82 M. This is 99.42% lower than that of the Biotechnology sector and 98.53% lower than that of the Health Care industry. The market capitalization for all United States stocks is 99.46% higher than that of the company.
CAMP4 Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CAMP4 THERAPEUTICS's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CAMP4 THERAPEUTICS could also be used in its relative valuation, which is a method of valuing CAMP4 THERAPEUTICS by comparing valuation metrics of similar companies.CAMP4 THERAPEUTICS is currently under evaluation in market capitalization category among its peers.
CAMP4 Fundamentals
| Current Valuation | 109.74 M | ||||
| Shares Outstanding | 20.16 M | ||||
| Shares Owned By Insiders | 35.40 % | ||||
| Shares Owned By Institutions | 56.95 % | ||||
| Number Of Shares Shorted | 265.54 K | ||||
| Price To Earning | 318.57 X | ||||
| Revenue | 652 K | ||||
| Gross Profit | (37.93 M) | ||||
| EBITDA | (51.39 M) | ||||
| Net Income | (51.79 M) | ||||
| Cash And Equivalents | 47.72 M | ||||
| Cash Per Share | 1.29 X | ||||
| Total Debt | 8.65 M | ||||
| Current Ratio | 1.86 X | ||||
| Book Value Per Share | (158.04) X | ||||
| Cash Flow From Operations | (45.56 M) | ||||
| Short Ratio | 3.48 X | ||||
| Earnings Per Share | (2.64) X | ||||
| Price To Earnings To Growth | 0.08 X | ||||
| Target Price | 19.91 | ||||
| Number Of Employees | 55 | ||||
| Beta | 1.89 | ||||
| Market Capitalization | 102.82 M | ||||
| Total Asset | 78.31 M | ||||
| Retained Earnings | (211.75 M) | ||||
| Working Capital | 56.78 M | ||||
| Current Asset | 298.77 M | ||||
| Current Liabilities | 49.56 M | ||||
| Net Asset | 78.31 M |
About CAMP4 THERAPEUTICS Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CAMP4 THERAPEUTICS PORATION's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CAMP4 THERAPEUTICS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CAMP4 THERAPEUTICS PORATION based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with CAMP4 THERAPEUTICS
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CAMP4 THERAPEUTICS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CAMP4 THERAPEUTICS will appreciate offsetting losses from the drop in the long position's value.Moving together with CAMP4 Stock
Moving against CAMP4 Stock
| 0.77 | CICHF | China Construction Bank | PairCorr |
| 0.76 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
| 0.66 | A | Agilent Technologies Earnings Call Tomorrow | PairCorr |
| 0.65 | PTHL | Pheton Holdings | PairCorr |
| 0.63 | BNTX | BioNTech SE Earnings Call Tomorrow | PairCorr |
The ability to find closely correlated positions to CAMP4 THERAPEUTICS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CAMP4 THERAPEUTICS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CAMP4 THERAPEUTICS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CAMP4 THERAPEUTICS PORATION to buy it.
The correlation of CAMP4 THERAPEUTICS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CAMP4 THERAPEUTICS moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CAMP4 THERAPEUTICS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CAMP4 THERAPEUTICS can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for CAMP4 Stock Analysis
When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.